Clinical Trials Logo
  1. Home
  2. Cardiac Transplantation
  3. NCT00170794

Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.

Cardiac Transplantation Clinical Trial

Official title:
A One Year, Multicenter, Open-Label, Single Arm, Pilot Study of the Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.

Clinical Trial Summary

The purpose of the study is to determine the extent of cyclosporine microemulsion dose reduction required to maintain stable renal function in maintenance cardiac transplant recipients, after initiation of everolimus.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00170794
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 3
Start date September 2004
View Details
See also
  Status Clinical Trial Phase
Completed NCT02672683 - Non Invasive Detection of Cardiac Allograft Rejection by Circulating microRNAs
Completed NCT01017029 - Everolimus in de Novo Heart Transplant Recipients Phase 4
Terminated NCT00338455 - Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC Phase 2
Completed NCT00000412 - Osteoporosis Prevention After Heart Transplant Phase 3
Completed NCT00716573 - Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure Phase 4
Completed NCT02255123 - Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study N/A
Active, not recruiting NCT00799188 - CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial Phase 3
Terminated NCT00284531 - Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients Phase 1/Phase 2
Active, not recruiting NCT05904678 - Anatomical and Functional Assessment of Ex-vivo Coronary Perfusion
Terminated NCT01235910 - Clinical Pharmacology of Aliskiren in Combination With Cyclosporine in Cardiac Transplantation Phase 4
Active, not recruiting NCT00581321 - Oral Water Ingestion in Heart Transplant Patients N/A
Terminated NCT00166153 - Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept N/A
Completed NCT00414895 - Absolute Myocardial Perfusion Measurement in the Transplanted Heart N/A
Completed NCT03145441 - Intraoperative Use of Extracorporeal Cytokine Adsorption During Orthotopic Heart Transplantation N/A